Identifying a 6-Gene Prognostic Signature for Lung Adenocarcinoma Based on Copy Number Variation and Gene Expression Data.

Huang Y, Qiu L, Liang X, Zhao J, Chen H, Luo Z, Li W, Lin X, Jin J, Huang J, Zhang G.

Open source

DOI
10.1155/2022/6962163
Published
2022-09-28
Container
Oxid Med Cell Longev
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1155/2022/6962163,
  title = {Identifying a 6-Gene Prognostic Signature for Lung Adenocarcinoma Based on Copy Number Variation and Gene Expression Data.},
  author = {Huang Y and  Qiu L and  Liang X and  Zhao J and  Chen H and  Luo Z and  Li W and  Lin X and  Jin J and  Huang J and  Zhang G.},
  year = {2022},
  journal = {Oxid Med Cell Longev},
  doi = {10.1155/2022/6962163},
  url = {https://doi.org/10.1155/2022/6962163}
}

RIS

TY  - JOUR
TI  - Identifying a 6-Gene Prognostic Signature for Lung Adenocarcinoma Based on Copy Number Variation and Gene Expression Data.
AU  - Huang Y
AU  -  Qiu L
AU  -  Liang X
AU  -  Zhao J
AU  -  Chen H
AU  -  Luo Z
AU  -  Li W
AU  -  Lin X
AU  -  Jin J
AU  -  Huang J
AU  -  Zhang G.
PY  - 2022
JO  - Oxid Med Cell Longev
DO  - 10.1155/2022/6962163
UR  - https://doi.org/10.1155/2022/6962163
ER  - 

APA

Y, H., L, Q., X, L., J, Z., H, C., Z, L., W, L., X, L., J, J., J, H., & G., Z. (2022). Identifying a 6-Gene Prognostic Signature for Lung Adenocarcinoma Based on Copy Number Variation and Gene Expression Data.. Oxid Med Cell Longev. https://doi.org/10.1155/2022/6962163

Source records